No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Adjuvant pembrolizumab does not reduce health-related quality of life in patients with stage III melanoma

byTeddy Guo

May 12, 2021

in StudyGraphics

Reading Time: 1 min read

Click to read the study in The Lancet Oncology.

Click to see previously reported survival outcomes from the same cohort.

RELATED REPORTS

Sacituzumab govitecan plus pembrolizumab improves survival in advanced triple-negative breast cancer

2MM: AI Roundup –Lilly launches TuneLab AI drug discovery, smart wound healing bandage, and Punjab cancer screening [September 25th, 2025]

Samsung BioLogics lands $1.3 billion U.S. contract amid tariff uncertainty

Antiretroviral therapy deferral associated with increased AIDS-defining cancer risk

RelatedReports

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Oncology

Sacituzumab govitecan plus pembrolizumab improves survival in advanced triple-negative breast cancer

January 28, 2026

AI Roundup

2MM: AI Roundup –Lilly launches TuneLab AI drug discovery, smart wound healing bandage, and Punjab cancer screening [September 25th, 2025]

September 28, 2025

Adalimumab use results in high clinical response rate in hidradenitis suppurativa

All Specialties

Samsung BioLogics lands $1.3 billion U.S. contract amid tariff uncertainty

September 23, 2025

2 Minute Medicine Rewind January 28, 2019

Psychiatry

A digital psychological intervention is associated with improved psychological outcomes in patients with inflammatory rheumatic diseases

January 13, 2026

Early feeding practices modifiable through appropriate education

Preterm formula powder is not inferior to human milk fortifier as breast milk fortifier

Social networks play key roles in parental vaccination decisions

Contingency management programs linked to decreased cocaine use among adults

Seminal vesicle invasion predicts decreased survival in bladder cancer

Routine urinary tract cancer testing among all patients with microhematuria has low diagnostic yield

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result